NCT07279792

Brief Summary

This randomized controlled trial will evaluate the efficacy of three bladder irrigation solutions - distilled water (DW), normal saline (NS), and hypertonic saline (HS) - as continuous bladder irrigation (CBI) following transurethral resection of non-muscle invasive bladder cancer (NMIBC). Short term (6 months) recurrence and progression free survival are mainly evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 12, 2025

Completed
Last Updated

December 29, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

December 1, 2025

Last Update Submit

December 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Risk of Recurrence

    6 months

  • Risk of progression of bladder cancer

    6 months

Study Arms (3)

Continuous Bladder Irrigation with distilled water

ACTIVE COMPARATOR
Drug: Continuous Bladder Irrigation with distilled water

Continuous Bladder Irrigation with normal saline

ACTIVE COMPARATOR
Drug: Continuous Bladder Irrigation with normal saline

Continuous Bladder Irrigation with hypertonic saline

ACTIVE COMPARATOR
Drug: Continuous Bladder Irrigation with hypertonic saline

Interventions

Continuous Bladder Irrigation with normal saline post non muscle invasive bladder cancer urethral resection by endoscopy

Continuous Bladder Irrigation with normal saline

Continuous Bladder Irrigation with hypertonic saline post non muscle invasive bladder cancer urethral resection by endoscopy

Continuous Bladder Irrigation with hypertonic saline

Continuous Bladder Irrigation with distilled water post non muscle invasive bladder cancer urethral resection by endoscopy

Continuous Bladder Irrigation with distilled water

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of non-muscle invasive urinary bladder urothelial carcinoma amenable for complete resection

You may not qualify if:

  • Patients with post-operative complications that need prolonged irrigation.
  • Patient who underwent incomplete resection during TURBT.
  • When large bladder perforation was suspected during TURBT.
  • Patients with chronic kidney disease.
  • Muscle invasive disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Egypt

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Saline SolutionSaline Solution, Hypertonic

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical PreparationsHypertonic Solutions

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2025

First Posted

December 12, 2025

Study Start

October 1, 2024

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

December 29, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Locations